Open81.280 | Close84.440 |
Vol / Avg.1.319M / 1.500M | Mkt Cap7.881B |
Day Range78.670 - 84.500 | 52 Wk Range55.250 - 159.890 |
Sarepta Therapeutics Stock (NASDAQ: SRPT) stock price, news, charts, stock research, profile.
Open81.280 | Close84.440 |
Vol / Avg.1.319M / 1.500M | Mkt Cap7.881B |
Day Range78.670 - 84.500 | 52 Wk Range55.250 - 159.890 |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.320 | 0.370 | 1.6900 | ||||
REV | 288.500M | 331.817M | 43.317M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-21 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 148.00 |
2023-11-21 | Wedbush | Andreas Argyrides | Initiates Coverage On | Outperform | Announces | - | 224.00 |
2023-11-02 | Barclays | Gena Wang | Maintains | OverweightOverweight | Lowers | 193.00 | 141.00 |
2023-11-02 | Cantor Fitzgerald | Kristen Kluska | Maintains | NeutralNeutral | Raises | 40.00 | 80.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SRPT | Sarepta Therapeutics | 3.65% | 7.9B |
LEGN | Legend Biotech | -1.36% | 10.9B |
EXAS | Exact Sciences | 4.7% | 12.1B |
NBIX | Neurocrine Biosciences | 0.87% | 11.6B |
KRTX | Karuna Therapeutics | 2.78% | 7.4B |
You can purchase shares of Sarepta Therapeutics (NASDAQ: SRPT) through any online brokerage.
Other companies in Sarepta Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Karuna Therapeutics (NASDAQ:KRTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
The latest price target for Sarepta Therapeutics (NASDAQ: SRPT) was reported by RBC Capital on Tuesday, November 21, 2023. The analyst firm set a price target for 148.00 expecting SRPT to rise to within 12 months (a possible 75.67% upside). 69 analyst firms have reported ratings in the last year.
The stock price for Sarepta Therapeutics (NASDAQ: SRPT) is $84.25 last updated December 1, 2023 at 11:27 PM UTC.
There is no dividend information for Sarepta Therapeutics.
Sarepta Therapeutics’s Q4 earnings are confirmed for Tuesday, February 27, 2024.
There is no upcoming split for Sarepta Therapeutics.
Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.